Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism

Sharon Andrea Hoey, P S Grabowski, S H Ralston, J V Forrester, J Liversidge

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The production of large amounts of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) has been described as a double-edged sword eliciting pro- or anti-inflammatory effects in different immune situations. Our aim, therefore, was to investigate its role in experimental autoimmune uveoretinitis (EAU), a model of ocular inflammation, induced in the Lewis rat following a single footpad injection of retinal Ags. iNOS enzyme was not detected in the normal Lewis rat eye, but was strongly expressed by infiltrating ED1+ macrophages during the acute inflammatory stages of EAU. Treating immunized animals with L-arginine increased urinary NO metabolite (NOx) levels, accelerated the inflammatory response, and increased disease severity, whereas treatment with the NOS inhibitor, N(G)-nitro-L-arginine methyl ester, reduced NOx excretion, delayed the onset, and reduced the clinical signs of EAU. Reverse transcription-PCR analysis of ocular tissue from untreated and treated animals detected iNOS mRNA at all stages of disease, and expression was up-regulated during peak disease. L-arginine treatment enhanced cytokine mRNA expression, particularly of IFN-gamma, which was detected earlier than in control animals, corresponding with the more rapid onset of disease and increased disease severity observed in this group. N(G)-nitro-L-arginine methyl ester had little or no effect on iNOS or inflammatory cytokine mRNA expression. These results suggest NO is central to the pathogenesis of EAU and highlight the importance of the macrophage as an effector cell in what is considered a CD4+ T cell-dependent disease. Furthermore, this study demonstrates the therapeutic potential of NOS inhibitors in the treatment of inflammatory and autoimmune mediated disease.
Original languageEnglish
Pages (from-to)5132-5142
Number of pages11
JournalThe Journal of Immunology
Volume159
Issue number10
Publication statusPublished - 15 Nov 1997

Fingerprint

Nitric Oxide
Nitric Oxide Synthase Type II
NG-Nitroarginine Methyl Ester
Messenger RNA
Arginine
Macrophages
Cytokines
Therapeutics
Autoimmune Diseases
Reverse Transcription
Anti-Inflammatory Agents
Inflammation
T-Lymphocytes
Polymerase Chain Reaction
Injections
Enzymes

Keywords

  • Animals
  • Arginine
  • Autoimmune Diseases
  • Cytokines
  • Immunohistochemistry
  • Interferon-gamma
  • Male
  • NG-Nitroarginine Methyl Ester
  • Nitrates
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Nitrites
  • RNA, Messenger
  • Rats
  • Rats, Inbred Lew
  • Retinitis
  • Uveitis

Cite this

Hoey, S. A., Grabowski, P. S., Ralston, S. H., Forrester, J. V., & Liversidge, J. (1997). Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. The Journal of Immunology, 159(10), 5132-5142.

Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. / Hoey, Sharon Andrea; Grabowski, P S; Ralston, S H; Forrester, J V; Liversidge, J.

In: The Journal of Immunology, Vol. 159, No. 10, 15.11.1997, p. 5132-5142.

Research output: Contribution to journalArticle

Hoey, SA, Grabowski, PS, Ralston, SH, Forrester, JV & Liversidge, J 1997, 'Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism', The Journal of Immunology, vol. 159, no. 10, pp. 5132-5142.
Hoey, Sharon Andrea ; Grabowski, P S ; Ralston, S H ; Forrester, J V ; Liversidge, J. / Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. In: The Journal of Immunology. 1997 ; Vol. 159, No. 10. pp. 5132-5142.
@article{c0c42c4a68cd433fa66bbb77e45bd170,
title = "Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism",
abstract = "The production of large amounts of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) has been described as a double-edged sword eliciting pro- or anti-inflammatory effects in different immune situations. Our aim, therefore, was to investigate its role in experimental autoimmune uveoretinitis (EAU), a model of ocular inflammation, induced in the Lewis rat following a single footpad injection of retinal Ags. iNOS enzyme was not detected in the normal Lewis rat eye, but was strongly expressed by infiltrating ED1+ macrophages during the acute inflammatory stages of EAU. Treating immunized animals with L-arginine increased urinary NO metabolite (NOx) levels, accelerated the inflammatory response, and increased disease severity, whereas treatment with the NOS inhibitor, N(G)-nitro-L-arginine methyl ester, reduced NOx excretion, delayed the onset, and reduced the clinical signs of EAU. Reverse transcription-PCR analysis of ocular tissue from untreated and treated animals detected iNOS mRNA at all stages of disease, and expression was up-regulated during peak disease. L-arginine treatment enhanced cytokine mRNA expression, particularly of IFN-gamma, which was detected earlier than in control animals, corresponding with the more rapid onset of disease and increased disease severity observed in this group. N(G)-nitro-L-arginine methyl ester had little or no effect on iNOS or inflammatory cytokine mRNA expression. These results suggest NO is central to the pathogenesis of EAU and highlight the importance of the macrophage as an effector cell in what is considered a CD4+ T cell-dependent disease. Furthermore, this study demonstrates the therapeutic potential of NOS inhibitors in the treatment of inflammatory and autoimmune mediated disease.",
keywords = "Animals, Arginine, Autoimmune Diseases, Cytokines, Immunohistochemistry, Interferon-gamma, Male, NG-Nitroarginine Methyl Ester, Nitrates, Nitric Oxide, Nitric Oxide Synthase, Nitrites, RNA, Messenger, Rats, Rats, Inbred Lew, Retinitis, Uveitis",
author = "Hoey, {Sharon Andrea} and Grabowski, {P S} and Ralston, {S H} and Forrester, {J V} and J Liversidge",
year = "1997",
month = "11",
day = "15",
language = "English",
volume = "159",
pages = "5132--5142",
journal = "The Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism

AU - Hoey, Sharon Andrea

AU - Grabowski, P S

AU - Ralston, S H

AU - Forrester, J V

AU - Liversidge, J

PY - 1997/11/15

Y1 - 1997/11/15

N2 - The production of large amounts of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) has been described as a double-edged sword eliciting pro- or anti-inflammatory effects in different immune situations. Our aim, therefore, was to investigate its role in experimental autoimmune uveoretinitis (EAU), a model of ocular inflammation, induced in the Lewis rat following a single footpad injection of retinal Ags. iNOS enzyme was not detected in the normal Lewis rat eye, but was strongly expressed by infiltrating ED1+ macrophages during the acute inflammatory stages of EAU. Treating immunized animals with L-arginine increased urinary NO metabolite (NOx) levels, accelerated the inflammatory response, and increased disease severity, whereas treatment with the NOS inhibitor, N(G)-nitro-L-arginine methyl ester, reduced NOx excretion, delayed the onset, and reduced the clinical signs of EAU. Reverse transcription-PCR analysis of ocular tissue from untreated and treated animals detected iNOS mRNA at all stages of disease, and expression was up-regulated during peak disease. L-arginine treatment enhanced cytokine mRNA expression, particularly of IFN-gamma, which was detected earlier than in control animals, corresponding with the more rapid onset of disease and increased disease severity observed in this group. N(G)-nitro-L-arginine methyl ester had little or no effect on iNOS or inflammatory cytokine mRNA expression. These results suggest NO is central to the pathogenesis of EAU and highlight the importance of the macrophage as an effector cell in what is considered a CD4+ T cell-dependent disease. Furthermore, this study demonstrates the therapeutic potential of NOS inhibitors in the treatment of inflammatory and autoimmune mediated disease.

AB - The production of large amounts of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) has been described as a double-edged sword eliciting pro- or anti-inflammatory effects in different immune situations. Our aim, therefore, was to investigate its role in experimental autoimmune uveoretinitis (EAU), a model of ocular inflammation, induced in the Lewis rat following a single footpad injection of retinal Ags. iNOS enzyme was not detected in the normal Lewis rat eye, but was strongly expressed by infiltrating ED1+ macrophages during the acute inflammatory stages of EAU. Treating immunized animals with L-arginine increased urinary NO metabolite (NOx) levels, accelerated the inflammatory response, and increased disease severity, whereas treatment with the NOS inhibitor, N(G)-nitro-L-arginine methyl ester, reduced NOx excretion, delayed the onset, and reduced the clinical signs of EAU. Reverse transcription-PCR analysis of ocular tissue from untreated and treated animals detected iNOS mRNA at all stages of disease, and expression was up-regulated during peak disease. L-arginine treatment enhanced cytokine mRNA expression, particularly of IFN-gamma, which was detected earlier than in control animals, corresponding with the more rapid onset of disease and increased disease severity observed in this group. N(G)-nitro-L-arginine methyl ester had little or no effect on iNOS or inflammatory cytokine mRNA expression. These results suggest NO is central to the pathogenesis of EAU and highlight the importance of the macrophage as an effector cell in what is considered a CD4+ T cell-dependent disease. Furthermore, this study demonstrates the therapeutic potential of NOS inhibitors in the treatment of inflammatory and autoimmune mediated disease.

KW - Animals

KW - Arginine

KW - Autoimmune Diseases

KW - Cytokines

KW - Immunohistochemistry

KW - Interferon-gamma

KW - Male

KW - NG-Nitroarginine Methyl Ester

KW - Nitrates

KW - Nitric Oxide

KW - Nitric Oxide Synthase

KW - Nitrites

KW - RNA, Messenger

KW - Rats

KW - Rats, Inbred Lew

KW - Retinitis

KW - Uveitis

M3 - Article

C2 - 9366443

VL - 159

SP - 5132

EP - 5142

JO - The Journal of Immunology

JF - The Journal of Immunology

SN - 0022-1767

IS - 10

ER -